U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ASCRINVACUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
PF-03446962
Preferred Name English
ASCRINVACUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G2, ANTI-(HUMAN ACTIVIN RECEPTOR-LIKE KINASE 1) (HUMAN MONOCLONAL PF-03446962 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-03446962 LIGHT CHAIN, DIMER
Common Name English
ascrinvacumab [INN]
Common Name English
GT-90001
Code English
GT90001
Code English
PF03446962
Code English
Ascrinvacumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
Code System Code Type Description
FDA UNII
716FQ5REVO
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
DRUG BANK
DB12261
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
USAN
BC-56
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
SMS_ID
100000167442
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
NCI_THESAURUS
C91073
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
CAS
1463459-96-2
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
INN
10106
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109295
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
EVMPD
SUB181657
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
WIKIPEDIA
Ascrinvacumab
Created by admin on Mon Mar 31 21:31:38 GMT 2025 , Edited by admin on Mon Mar 31 21:31:38 GMT 2025
PRIMARY
ACTIVE MOIETY
ASCRINVACUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966